Craft Tropolis

Main Menu

  • Home
  • YMPE
  • Price earnings ratio
  • Exchange risk
  • Stock index swap
  • Cash

Craft Tropolis

Header Banner

Craft Tropolis

  • Home
  • YMPE
  • Price earnings ratio
  • Exchange risk
  • Stock index swap
  • Cash
Exchange risk
Home›Exchange risk›Field Trip Health Ltd. obtains conditional approval for its update on the Toronto Stock Exchange

Field Trip Health Ltd. obtains conditional approval for its update on the Toronto Stock Exchange

By Rachel Smallwood
May 27, 2021
0
0




Enter Wall Street with StreetInsider Premium. Claim your 1-week free trial here.


TORONTO, May 27, 2021 (GLOBE NEWSWIRE) – Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“Excursion“), a leader in the development and delivery of psychedelic therapies, is pleased to announce that it has received conditional approval to list its common shares and warrants on the Toronto Stock Exchange (TSX). Listing is conditional on the Company meeting certain requirements of the TSX in accordance with the terms of its conditional approval letter dated May 26, 2021.

Field Trip is actively working to meet the requirements and conditions that were outlined in the approval letter and management is confident that all registration requirements will be met in the coming weeks. After obtaining final approval, the company will issue an additional press release to notify shareholders when it expects its common shares to begin trading on the TSX.

Once the final listing requirements are met, the Company’s common shares will be delisted from the CSE and will begin trading on the TSX under the symbol “FTRP” and the warrants will trade under the symbol “FTRP- WT ”. The Company’s shares will continue to trade on the OTCQX market under the symbol “FTRPF”.

Joseph del Moral, CEO of Field Trip, said: “Receiving conditional acceptance to move to Canada’s largest stock exchange is a milestone for Field Trip and for the emerging psychedelic industry in general. While our TSX listing will provide greater visibility for Field Trip in the markets and expand our access to other Canadian and international investors, we continue to work on improving liquidity for global investors in Field Trip, including by exploring cross-listings on US stock exchanges. . “

About Field Trip Health Ltd.

Field Trip is a global leader in the development and delivery of psychedelic therapies. With our Field Trip Discovery division leading the development of the next generation of psychedelic molecules and leading advanced research on herbal psychedelics and our Field Trip Health division building centers for psychedelic therapies in North America and Europe as well as digital and technological tools that will enable on a massive scale, we are helping those in need with a simple, factual way to heal and strengthen engagement with the world.

Learn more about https://www.meetfieldtrip.com, https://www.fieldtriphealth.com and https://www.fieldtriphealth.nl.

Follow us on Twitter and Instagram: @fieldtriphealth

To receive company updates on Field Trip and to be added to the email distribution list, please subscribe here.

For more information, contact Ronan Levy, Executive Chairman and Director of Field Trip, at 1 (833) 833-1967.

Caution regarding forward-looking information.

This press release contains forward-looking information within the meaning of Canadian securities laws regarding Field Trip and its activities, which may include, but are not limited to, statements relating to Field Trip’s intended use of the proceeds of the offering. Often, but not always, forward-looking information can be identified by the use of words such as “expect”, “intend”, “anticipate”, “believe” or variations (including negative variations) of these words and expressions, or indicate that certain actions, events or results “may”, “could”, “would” or “will” be undertaken, will occur or will be achieved. These statements are based on the current expectations and opinions on future events of the management of Field Trip, and are based on assumptions and subject to risks and uncertainties. Although the management of Field Trip believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially due to known and unknown risk factors and uncertainties affecting businesses, including risks regarding the COVID-19 outbreak, the medical clinic industry, market conditions, economics, management’s ability to manage and operate the business and the stock markets in general. Although Field Trip has attempted to identify material factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or or results differ from those expected, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking statements or information. No forward-looking statement can be guaranteed. Unless required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Field Trip undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

Neither the Canadian Securities Exchange, nor the Toronto Stock Exchange, nor their regulatory services provider, nor the over-the-counter markets have approved the contents of this press release nor accept responsibility for the adequacy or the adequacy of this release. accuracy of this release.

Media contacts:Rachel Moskowitz Fall Communications202-276-7881[email protected]

Nick Opich / McKenna MillerKCSA Strategic Communications212-896-1206 / 347-487-6197[email protected]

Ania Gilbert – Canadian MediaPomp & Circumstance647-273-9869[email protected]

Investor contacts:Elizabeth BarkerKCSA Strategic Communications212-896-1203[email protected]

SOURCE Field Trip Health Ltd.

Source: Field Trip Health, Ltd.



Related posts:

  1. Axington, linked to Loh’s cousins, now a treasury firm liable to delisting, Corporations and Markets Information
  2. Laurentian Financial institution broadcasts the election of its administrators Toronto Inventory Alternate: LB
  3. Traders brace for Asia’s worst inventory market downturn
  4. British Columbia dwelling care employee sufferer of $ 90,000 wire fraud in China

Recent Posts

  • What do the fundamentals predict for Williams-Sonoma, Inc. (WSM) stock?
  • These stocks soared 20% on Tuesday, hitting an all-time high: what’s driving the rally?
  • Positivity May Emerge for Nasdaq-100 ETFs
  • Willdan Group, Inc. (NASDAQ:WLDN) is expected to report earnings of $0.21 per share
  • ‘Fat finger’ swap: Payment could be delayed as NSE ‘looks into’ issue

Archives

  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • January 2021
  • December 2020
  • November 2020
  • July 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • November 2019
  • October 2019
  • September 2019
  • January 2019
  • December 2018
  • September 2018
  • May 2018
  • November 2017
  • March 2017
  • November 2015
  • September 2015

Categories

  • Cash
  • Exchange risk
  • Price earnings ratio
  • Stock index swap
  • YMPE
  • TERMS AND CONDITIONS
  • Privacy and policy